Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI Europe Health Care 20/35 Capped |
| Investment focus | Equity, Europe, Health Care |
| Fund size | GBP 713 m |
| Total expense ratio | 0.18% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 16.10% |
| Inception/ Listing Date | 17 November 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | BlackRock Advisors (UK) Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 31 March |
| Swiss representative | NO |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | No |
| Securities lending counterparty |
| AstraZeneca PLC | 16.54% |
| Novartis AG | 15.74% |
| Roche Holding AG | 15.14% |
| Novo Nordisk A/S | 6.31% |
| GSK Plc | 6.10% |
| Sanofi | 5.76% |
| EssilorLuxottica SA | 3.79% |
| Bayer AG | 2.45% |
| argenx | 2.44% |
| Lonza Group AG | 2.43% |
| United Kingdom | 25.75% |
| Switzerland | 22.16% |
| France | 10.48% |
| Germany | 6.19% |
| Other | 35.42% |
| Health Care | 67.73% |
| Consumer Discretionary | 3.79% |
| Consumer Staples | 2.42% |
| Other | 26.06% |
| YTD | -1.77% |
| 1 month | +1.84% |
| 3 months | -6.30% |
| 6 months | -1.29% |
| 1 year | +11.52% |
| 3 years | +8.93% |
| 5 years | +34.96% |
| Since inception (MAX) | +38.01% |
| 2025 | +13.32% |
| 2024 | -0.54% |
| 2023 | +6.17% |
| 2022 | +0.97% |
| Volatility 1 year | 16.10% |
| Volatility 3 years | 15.62% |
| Volatility 5 years | 15.47% |
| Return per risk 1 year | 0.72 |
| Return per risk 3 years | 0.18 |
| Return per risk 5 years | 0.40 |
| Maximum drawdown 1 year | -13.52% |
| Maximum drawdown 3 years | -24.54% |
| Maximum drawdown 5 years | -24.54% |
| Maximum drawdown since inception | -24.54% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | ESIH | - - | - - | - |
| London Stock Exchange | GBP | ESIH | ESIH LN | ESIH.L | |
| XETRA | EUR | ESIH | ESIH GY INAVESI6 | ESIH.DE 4JRPEUR=INAV |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| State Street SPDR MSCI Europe Health Care UCITS ETF EUR | 518 | 0.18% p.a. | Accumulating | Full replication |